Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Moriarty

Showing results (291-300 of 427) with videos related to

Pageof 43
Sort By:
Journal of Clinical Lipidology|December 16, 2014
Efficacy and safety of alirocumab, a monoclonal antibody to PCSK9, in statin-intolerant patients: design and rationale of ODYSSEY ALTERNATIVE, a randomized phase 3 trialPatrick M Moriarty, Terry A Jacobson, Eric Bruckert, et al.
Cancer Research|January 15, 1997
Cancer chemopreventive potential of sulforamate, a novel analogue of sulforaphane that induces phase 2 drug-metabolizing enzymesC Gerhäuser, M You, J Liu, et al.
Neurosurgery|August 1, 1997
Computer-assisted surgical planning for cerebrovascular neurosurgeryS Nakajima, H Atsumi, A H Bhalerao, et al.
Antimicrobial Agents and Chemotherapy|May 25, 2004
alpha-Galactosylceramide and novel synthetic glycolipids directly induce the innate host defense pathway and have direct activity against hepatitis B and C virusesAnand S Mehta, Baohua Gu, Bertha Conyers, et al.
Case Reports in Women'S Health|March 30, 2023
Use of an aortic balloon to achieve uterine conservation in a case of placenta accreta spectrum: A case reportHelena C Bartels, David P Brophy, John M Moriarty, et al.
Water Research|August 13, 2005
The prevalence and characterisation of Cryptosporidium spp. in beef abattoir water suppliesJ M McEvoy, G Duffy, E M Moriarty, et al.
Clinical Radiology|November 7, 2022
Cost drivers in endovascular pulmonary embolism interventionsT E Callese, J M Moriarty, C Maehara, et al.
Journal of Clinical Apheresis|February 1, 2017
Case report of male child with elevated lipoprotein (a) leading to acute ischemic strokePatrick M Moriarty, Heather Tennant, Nandhini Sehar, et al.
Atherosclerosis|September 19, 2016
A phase III randomized trial evaluating alirocumab 300 mg every 4 weeks as monotherapy or add-on to statin: ODYSSEY CHOICE IEli M Roth, Patrick M Moriarty, Jean Bergeron, et al.
Journal of Clinical Lipidology|February 12, 2015
Statins and almonds to lower lipoproteins (the STALL Study)Janelle F Ruisinger, Cheryl A Gibson, James M Backes, et al.
Pageof 43

Showing results (291-300 of 427) with videos related to

Sort By:
Pageof 43
Journal of Clinical Lipidology|December 16, 2014
Efficacy and safety of alirocumab, a monoclonal antibody to PCSK9, in statin-intolerant patients: design and rationale of ODYSSEY ALTERNATIVE, a randomized phase 3 trialPatrick M Moriarty, Terry A Jacobson, Eric Bruckert, et al.
Cancer Research|January 15, 1997
Cancer chemopreventive potential of sulforamate, a novel analogue of sulforaphane that induces phase 2 drug-metabolizing enzymesC Gerhäuser, M You, J Liu, et al.
Neurosurgery|August 1, 1997
Computer-assisted surgical planning for cerebrovascular neurosurgeryS Nakajima, H Atsumi, A H Bhalerao, et al.
Antimicrobial Agents and Chemotherapy|May 25, 2004
alpha-Galactosylceramide and novel synthetic glycolipids directly induce the innate host defense pathway and have direct activity against hepatitis B and C virusesAnand S Mehta, Baohua Gu, Bertha Conyers, et al.
Case Reports in Women'S Health|March 30, 2023
Use of an aortic balloon to achieve uterine conservation in a case of placenta accreta spectrum: A case reportHelena C Bartels, David P Brophy, John M Moriarty, et al.
Water Research|August 13, 2005
The prevalence and characterisation of Cryptosporidium spp. in beef abattoir water suppliesJ M McEvoy, G Duffy, E M Moriarty, et al.
Clinical Radiology|November 7, 2022
Cost drivers in endovascular pulmonary embolism interventionsT E Callese, J M Moriarty, C Maehara, et al.
Journal of Clinical Apheresis|February 1, 2017
Case report of male child with elevated lipoprotein (a) leading to acute ischemic strokePatrick M Moriarty, Heather Tennant, Nandhini Sehar, et al.
Atherosclerosis|September 19, 2016
A phase III randomized trial evaluating alirocumab 300 mg every 4 weeks as monotherapy or add-on to statin: ODYSSEY CHOICE IEli M Roth, Patrick M Moriarty, Jean Bergeron, et al.
Journal of Clinical Lipidology|February 12, 2015
Statins and almonds to lower lipoproteins (the STALL Study)Janelle F Ruisinger, Cheryl A Gibson, James M Backes, et al.
Pageof 43